<DOC>
	<DOC>NCT00902382</DOC>
	<brief_summary>To identify adverse effects of ovulation drugs on pregnancy, including pregnancy loss, fetal teratology and dysmorphology, and infant development up to age 3.</brief_summary>
	<brief_title>Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications</brief_title>
	<detailed_description>This will be an observational cohort trial of the pregnancy of women who conceive in RMN trials, and of their resulting infants through the first 3 years of life. Study specific procedures will include a patient completed log of prescribed and over the counter medications taken during a normal pregnancy, a review of their pregnancy, delivery, and neonatal records, an exam of the infant within 60 days of birth by a dysmorphologist, and yearly review of infant medical records, growth charts, and a yearly parent administered developmental questionnaire (Ages and Stages) for the first three years of the infant's life.</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Positive serum hCG within the context of a RMN trial; History of infertility meeting female subject entry criteria for a RMN trial; Informed consent. Unable to comply with the demands of the trial.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Infertility</keyword>
	<keyword>Ovulation stimulation</keyword>
	<keyword>Pregnancy</keyword>
</DOC>